Selected research
Industry Research
Gastritis Treatment Drugs Industry Research Report 2026
Market perspective
The global Gastritis Treatment Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gastritis Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gastritis Treatment Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gastritis Treatment Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gastritis Treatment Drugs include Sun Pharmaceutical Industries, Novartis, Pfizer, AstraZeneca, Reddy's Laboratories, Perrigo Pharmaceutical, Microbiotix, Lupin Ltd and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gastritis Treatment Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gastritis Treatment Drugs Market by Company
Sun Pharmaceutical Industries
Novartis
Pfizer
AstraZeneca
Reddy's Laboratories
Perrigo Pharmaceutical
Microbiotix
Lupin Ltd
Cipla
Abbott Laboratories
Gastritis Treatment Drugs Segment by Type
Antibiotics
Antacids
Acid-Blocking Medicines
Histamine Blockers
Others
Gastritis Treatment Drugs Segment by Application
Hospitals
Clinics
Others
Gastritis Treatment Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastritis Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gastritis Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastritis Treatment Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gastritis Treatment Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gastritis Treatment Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gastritis Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibiotics
- Antacids
- Acid-Blocking Medicines
- Histamine Blockers
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Sun Pharmaceutical Industries
- Novartis
- Pfizer
- AstraZeneca
- Reddy's Laboratories
- Perrigo Pharmaceutical
- Microbiotix
- Lupin Ltd
- Cipla
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gastritis Treatment Drugs Market Size (2021-2032)
- 2.2.2 Global Gastritis Treatment Drugs Sales (2021-2032)
- 2.2.3 Global Gastritis Treatment Drugs Market Average Price (2021-2032)
- 2.3 Gastritis Treatment Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antibiotics
- 2.3.3 Antacids
- 2.3.4 Acid-Blocking Medicines
- 2.3.5 Histamine Blockers
- 2.3.6 Others
- 2.4 Gastritis Treatment Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gastritis Treatment Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gastritis Treatment Drugs Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Gastritis Treatment Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Gastritis Treatment Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Gastritis Treatment Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gastritis Treatment Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gastritis Treatment Drugs, Product Type & Application
- 3.8 Global Manufacturers of Gastritis Treatment Drugs, Established Date
- 3.9 Global Gastritis Treatment Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries
- 4.1.1 Sun Pharmaceutical Industries Company Information
- 4.1.2 Sun Pharmaceutical Industries Business Overview
- 4.1.3 Sun Pharmaceutical Industries Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Gastritis Treatment Drugs Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Gastritis Treatment Drugs Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Gastritis Treatment Drugs Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Gastritis Treatment Drugs Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Reddy's Laboratories
- 4.5.1 Reddy's Laboratories Company Information
- 4.5.2 Reddy's Laboratories Business Overview
- 4.5.3 Reddy's Laboratories Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Reddy's Laboratories Gastritis Treatment Drugs Product Portfolio
- 4.5.5 Reddy's Laboratories Recent Developments
- 4.6 Perrigo Pharmaceutical
- 4.6.1 Perrigo Pharmaceutical Company Information
- 4.6.2 Perrigo Pharmaceutical Business Overview
- 4.6.3 Perrigo Pharmaceutical Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Perrigo Pharmaceutical Gastritis Treatment Drugs Product Portfolio
- 4.6.5 Perrigo Pharmaceutical Recent Developments
- 4.7 Microbiotix
- 4.7.1 Microbiotix Company Information
- 4.7.2 Microbiotix Business Overview
- 4.7.3 Microbiotix Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Microbiotix Gastritis Treatment Drugs Product Portfolio
- 4.7.5 Microbiotix Recent Developments
- 4.8 Lupin Ltd
- 4.8.1 Lupin Ltd Company Information
- 4.8.2 Lupin Ltd Business Overview
- 4.8.3 Lupin Ltd Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lupin Ltd Gastritis Treatment Drugs Product Portfolio
- 4.8.5 Lupin Ltd Recent Developments
- 4.9 Cipla
- 4.9.1 Cipla Company Information
- 4.9.2 Cipla Business Overview
- 4.9.3 Cipla Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cipla Gastritis Treatment Drugs Product Portfolio
- 4.9.5 Cipla Recent Developments
- 4.10 Abbott Laboratories
- 4.10.1 Abbott Laboratories Company Information
- 4.10.2 Abbott Laboratories Business Overview
- 4.10.3 Abbott Laboratories Gastritis Treatment Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Abbott Laboratories Gastritis Treatment Drugs Product Portfolio
- 4.10.5 Abbott Laboratories Recent Developments
5 Global Gastritis Treatment Drugs Market Scenario by Region
- 5.1 Global Gastritis Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gastritis Treatment Drugs Sales by Region: 2021-2032
- 5.2.1 Global Gastritis Treatment Drugs Sales by Region: 2021-2026
- 5.2.2 Global Gastritis Treatment Drugs Sales by Region: 2027-2032
- 5.3 Global Gastritis Treatment Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Gastritis Treatment Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Gastritis Treatment Drugs Revenue by Region: 2027-2032
- 5.4 North America Gastritis Treatment Drugs Market Facts & Figures by Country
- 5.4.1 North America Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gastritis Treatment Drugs Sales by Country (2021-2032)
- 5.4.3 North America Gastritis Treatment Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Gastritis Treatment Drugs Market Facts & Figures by Country
- 5.5.1 Europe Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gastritis Treatment Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Gastritis Treatment Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Gastritis Treatment Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gastritis Treatment Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gastritis Treatment Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gastritis Treatment Drugs Market Facts & Figures by Country
- 5.7.1 South America Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gastritis Treatment Drugs Sales by Country (2021-2032)
- 5.7.3 South America Gastritis Treatment Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Gastritis Treatment Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gastritis Treatment Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gastritis Treatment Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gastritis Treatment Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Gastritis Treatment Drugs Sales by Type (2021-2032)
- 6.1.1 Global Gastritis Treatment Drugs Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Gastritis Treatment Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Gastritis Treatment Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Gastritis Treatment Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gastritis Treatment Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Gastritis Treatment Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gastritis Treatment Drugs Sales by Application (2021-2032)
- 7.1.1 Global Gastritis Treatment Drugs Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Gastritis Treatment Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Gastritis Treatment Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Gastritis Treatment Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gastritis Treatment Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Gastritis Treatment Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gastritis Treatment Drugs Value Chain Analysis
- 8.1.1 Gastritis Treatment Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gastritis Treatment Drugs Production Mode & Process
- 8.2 Gastritis Treatment Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gastritis Treatment Drugs Distributors
- 8.2.3 Gastritis Treatment Drugs Customers
9 Global Gastritis Treatment Drugs Analyzing Market Dynamics
- 9.1 Gastritis Treatment Drugs Industry Trends
- 9.2 Gastritis Treatment Drugs Industry Drivers
- 9.3 Gastritis Treatment Drugs Industry Opportunities and Challenges
- 9.4 Gastritis Treatment Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst